Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 3/20 | 0.48 |
| ▸ | CLK1 | P49759 | 2/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.45 |
| ▸ | GABRD | O14764 | 1/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.45 |
| ▸ | GABRE | P78334 | 1/20 | 0.45 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.45 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.45 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.45 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24732232 | 0.88 | DYRK1A (0.51) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL17207347 | 0.82 | GABRP (0.62) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL26495152 | 0.78 | GABRP (0.59) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL18668517 | 0.75 | GABRP (0.50) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL19660715 | 0.75 | GABRP (0.50) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL20311611 | 0.74 | KIF11 (0.65) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL20662954 | 0.74 | KIF11 (0.69) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL19046665 | 0.73 | DYRK1A (0.48) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL19046664 | 0.73 | DYRK1A (0.48) | DYRK1ACLK1GABRPGABRDGABRA1 | |
| SCHEMBL17445429 | 0.73 | GABRP (0.64) | DYRK1ACLK1GABRPGABRDGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290513-B2 | Compound containing 5-membered heterocycles, organic electronic device using same, and terminal comprising the latter | DUK SAN NEOLUX CO., LTD. (KR) | 2016-03-22 | — | — | US | disclosed |
| US-9290513-B2 | Compound containing 5-membered heterocycles, organic electronic device using same, and terminal comprising the latter | DUK SAN NEOLUX CO., LTD. (KR) | 2016-03-22 | — | — | US | disclosed |
| US-20150307514-A1 | COMPOUND CONTAINING 5-MEMBERED HETEROCYCLES, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL COMPRISING THE LATTER | DUK SAN NEOLUX CO., LTD. (KR) | 2015-10-29 | — | — | US | disclosed |
| US-20150307514-A1 | COMPOUND CONTAINING 5-MEMBERED HETEROCYCLES, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL COMPRISING THE LATTER | DUK SAN NEOLUX CO., LTD. (KR) | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150307514-A1 | COMPOUND CONTAINING 5-MEMBERED HETEROCYCLES, ORGANIC ELECTRONIC DEVICE USING SAME, AND TERMINAL COMPRISING THE LATTER | EMC2, AOC2, MCM5 | DYRK1A 4419/4885CLK1 2729/4885GABRP 4868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.